drug
lisaftoclax
Phase 3updated 3mo agoby $AAPG ASCENTAGE PHARMA GROUP INTERNATIONAL
Phase 3community read0 votes
indications
indications
Breast Cancer
all catalysts(0)
nothing on the calendar yet
Trials studying lisaftoclax
- phase1A Phase 1 Study Of FLAG Chemotherapy In Combination With Lisaftoclax And Pelcitoclax In Patients With Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia
- phase3A Pivotal Study of APG-2575 (Lisaftoclax) Combined With Azacitidine in the Treatment of Acute Myeloid Leukemia
- phase3Lisaftoclax (APG-2575) Combined With Azacytidine (AZA) in the Treatment of Patients With Higher-risk Myelodysplastic Syndrome (GLORA-4).
- phase2Study of Lisaftoclax (APG-2575) Single Agent and Combination With Therapy in Patients Relapsed/Refractory AML
- phase3Global Trial in APG2575 for Patients With CLL/SLL
- phase1Study of APG-2575 as a Single Agent or in Combination With Other Therapeutic Agents for CLL/SLL
- phase3A Global Study of Lisaftoclax (APG-2575) Combined With Acalabrutinib Versus Immunochemotherapy for Newly Diagnosed CLL/SLL.
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 30m ago
Found something off?
comments(0)
5-min edit window · permanent after that